SCHEMBL401641

SCHEMBL401641

CN(C)C(=O)c1cc(I)ccc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
HTT P42858 1/20 0.49
HKDC1 Q2TB90 1/20 0.45
SLC6A4 P31645 1/20 0.41
CASP6 P55212 1/20 0.41
FAAH O00519 1/20 0.41
MGLL Q99685 1/20 0.41
TSHR P16473 2/20 0.41
CYP3A4 P08684 1/20 0.41
DTYMK P23919 1/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
ERN1 O75460 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12261042 0.83 KMT2A (0.49) KMT2AHPGDMEN1NPSR1L3MBTL1
SCHEMBL1857955 0.82 ALDH1A1 (0.53) KMT2AHPGDMEN1NPSR1L3MBTL1
SCHEMBL3729240 0.82 TSHR (0.55) KMT2AHPGDMEN1NPSR1L3MBTL1
SCHEMBL13578450 0.81 MAPT (0.51) HTTCASP6TSHRCYP3A4DTYMK
SCHEMBL5508386 0.81 ATM (0.51) KMT2AHPGDMEN1NPSR1L3MBTL1
SCHEMBL399328 0.81 ALDH1A1 (0.54) KMT2AHPGDMEN1NPSR1L3MBTL1
SCHEMBL12562300 0.81 ALDH1A1 (0.57) KMT2AHPGDMEN1NPSR1L3MBTL1
SCHEMBL275456 0.80 DTYMK (0.62) KMT2AMEN1CASP6TSHRCYP3A4
SCHEMBL4391738 0.79 DTYMK (0.67) KMT2AHPGDMEN1NPSR1L3MBTL1
SCHEMBL12261040 0.79 KMT2A (0.46) KMT2AHPGDMEN1NPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA KMT2A 3181/4885HPGD 1174/4885MEN1 1018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.